Lenox Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $13K | Sell |
21
-3
| -13% | -$1.86K | ﹤0.01% | 433 |
|
|
2021
Q4 | $18K | Buy |
24
+3
| +14% | +$2.25K | ﹤0.01% | 416 |
|
|
2021
Q3 | $16K | Hold |
21
| – | – | ﹤0.01% | 394 |
|
|
2021
Q2 | $14K | Buy |
+21
| New | +$14K | ﹤0.01% | 418 |
|
|
2020
Q2 | – | Sell |
-48
| Closed | -$17K | – | 603 |
|
|
2020
Q1 | $17K | Buy |
+48
| New | +$17K | ﹤0.01% | 287 |
|
|
2019
Q2 | – | Sell |
-13
| Closed | -$4K | – | 425 |
|
|
2019
Q1 | $4K | Buy |
13
+1
| +8% | +$308 | ﹤0.01% | 387 |
|
|
2018
Q4 | $3K | Hold |
12
| – | – | ﹤0.01% | 312 |
|
|
2018
Q3 | $4K | Sell |
12
-82
| -87% | -$27.3K | ﹤0.01% | 319 |
|
|
2018
Q2 | $27K | Buy |
94
+42
| +81% | +$12.1K | 0.01% | 219 |
|
|
2018
Q1 | $13K | Buy |
52
+30
| +136% | +$7.5K | ﹤0.01% | 318 |
|
|
2017
Q4 | $5K | Buy |
+22
| New | +$5K | ﹤0.01% | 214 |
|